Exploring the Minimum CRRT Dose-Intensity: Evidence-Based Insights
-
By
-
Nuttha Lumlertgul
-
Sean M. Bagshaw
-
September 28, 2026
Clinical Report: Exploring the Minimum CRRT Dose-Intensity
Background
The dosing of continuous renal replacement therapy (CRRT) is critical in managing critically ill patients with acute kidney injury. Recent studies have reported associations between CRRT dose-intensity and mortality rates, necessitating further investigation into established dosing guidelines.
Data Highlights
No specific numerical data or trial data presented in the source material.
Key Findings
- Okamoto et al. reported a multivariable-adjusted hazard ratio of 1.73 (95% CI 1.19–2.51) for low CRRT dose-intensity.
- Faria and Libório provided a baseline-adjusted hazard ratio of 1.70 (95% CI 1.16–2.49) for the same threshold.
- Discrepancies in hazard ratios between studies indicate a need for clarification regarding the interpretation of CRRT dosing.
- Tran et al. found that low (<20 mL/kg/hr) and moderate (20–25 mL/kg/hr) CRRT doses were associated with lower 90-day mortality compared to higher doses (>25 mL/kg/hr).
- Further prospective confirmation is required regarding the existence of a minimum effective CRRT dose-intensity.
Clinical Implications
Evaluation of CRRT dosing strategies is necessary to optimize patient outcomes in critically ill populations.
Conclusion
Determining the optimal CRRT dose-intensity is complex and requires careful data interpretation.
Related Resources & Content
- Mei et al., Critical Care, 2026 -- Selection of Estimation Influences the Observed Mortality Threshold at 13 mL/kg/h
- Advancements in Renal Replacement Therapy Approaches, Intensive Care Medicine, 2025
- Improving Dose-Optimization Processes Used in Oncology Drug Development to Minimize Toxicity and Maximize Benefit to Patients, ASCO Publications, 2022
- KDIGO 2026 Acute Kidney Injury/Acute Kidney Disease Guideline, KDIGO, 2026
- Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury, NEJM, 2008
- ASCO Publications — Derivation of dose/volume constraints for the anorectum from clinician-reported outcomes (CRO) in the CHHiP trial of radiotherapy (RT) fractionation.
- Topic
- Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury | New England Journal of Medicine
- Lower versus standard dose-intensity continuous renal replacement therapy: a systematic review and meta-analysis - PubMed
Based on findings from:
Lower limits of CRRT dose-intensity: what does the evidence support?
Nuttha Lumlertgul, Sean M. Bagshaw. Critical Care, 2026.
https://link.springer.com/article/10.1186/s13054-026-06352-8
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
